Dr. Katarzyna Jerzak
Claim this profileSunnybrook Health Sciences Centre
Studies Breast Cancer
Studies Metastases
5 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
ER negative
2Metastases
ER negative
PR negative
HER2 negative
Affiliated Hospitals
Clinical Trials Katarzyna Jerzak is currently running
MRI Screening
for Brain Metastases in Breast Cancer
The goal of this multi-centre, prospective study is to assess the frequency of asymptomatic brain metastasis in patients with stage II or III Triple Negative or HER2 positive breast cancer. The main questions it aims to answer are: 1. What proportion of patients with stage II or III Triple Negative or HER2 positive breast cancer have asymptomatic brain metastases identified on a screening contrast-enhanced magnetic resonance imaging (or computed tomography when Magnetic resonance is not possible) of the brain? 2. How do patients feel about undergoing brain imaging to screen for asymptomatic Brain metastasis? 3. What clinical and tissue-based biomarkers are associated with asymptomatic detection of Brain metastasis? Participants will undergo a brain imaging, collect one blood sample to perform ctDNA analysis, and fill the Testing Morbidities Index (TMI) after imaging is done. Procedures must take place within one year of initial diagnosis, either prior to or after completion of (neo)-adjuvant systemic therapy.
Recruiting1 award N/A
Tucatinib + Radiation
for Breast Cancer
The proposed study will evaluate the safety and efficacy of XRT followed by systemic therapy among patients with HER2+ metastatic breast cancer and LMD
Recruiting1 award Phase 210 criteria
More about Katarzyna Jerzak
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Katarzyna Jerzak has experience with
- Placebo
- Trastuzumab
- Tucatinib
- Analysis Of Circulating Tumor DNA
- Brain Imaging
- Testing Morbidities Index
Breakdown of trials Katarzyna Jerzak has run
Breast Cancer
Breast cancer
Coronary Artery Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katarzyna Jerzak specialize in?
Katarzyna Jerzak focuses on Breast Cancer and Metastases. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Katarzyna Jerzak currently recruiting for clinical trials?
Yes, Katarzyna Jerzak is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Katarzyna Jerzak has studied deeply?
Yes, Katarzyna Jerzak has studied treatments such as Placebo, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Katarzyna Jerzak?
Apply for one of the trials that Katarzyna Jerzak is conducting.
What is the office address of Katarzyna Jerzak?
The office of Katarzyna Jerzak is located at: Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5 Canada. This is the address for their practice at the Sunnybrook Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.